Home › Funds › Kintegral Advisory, LLC › EW
Kintegral Advisory, LLC position in EW
EDWARDS LIFESCIENCES CORP · Health Care
Kintegral Advisory, LLC reported holding 63,507 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q2 2026 13F filing — a position valued at US$5.7M, representing 0.47% of its reported portfolio and ranking #49 among its reported holdings. Kintegral Advisory, LLC first reported this position in Q2 2026.
How Kintegral Advisory, LLC's EW position evolved
Kintegral Advisory, LLC first disclosed a stake in EW in Q2 2026 at 63,507 shares (US$5.7M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 63.51K | $5.74M | New |
About EW and 13F data
EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 218 other funds we track also report a position in EW — the largest reported positions include Vanguard Group (US$5.97B), BlackRock Inc (US$5.32B), VANGUARD CAPITAL MANAGEMENT LLC (US$3.40B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EW
- Vanguard Group 70.08M sh · $5.97B · Q4 2025
- BlackRock Inc 58.79M sh · $5.32B · Q2 2026
- VANGUARD CAPITAL MANAGEMENT LLC 37.62M sh · $3.40B · Q2 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC 26.41M sh · $2.39B · Q2 2026
- Wellington Management Group 16.83M sh · $1.52B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 16.83M sh · $1.52B · Q2 2026
- GEODE CAPITAL MANAGEMENT, LLC 15.44M sh · $1.39B · Q2 2026
- Geode Capital Management 15.44M sh · $1.39B · Q2 2026
- BNY Mellon 14.08M sh · $1.27B · Q2 2026
- DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt 13.00M sh · $1.18B · Q2 2026
- Ninety One UK Ltd 11.94M sh · $1.03B · Q3 2026
- Aristotle Capital Management, LLC 8.67M sh · $783.91M · Q2 2026